TENAX THERAPEUTICS, INC. Operating Expenses
TENAX THERAPEUTICS, INC. (TENX) reported Operating Expenses of $18.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-31
- TENAX THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $18.78M, a 59.29% increase year-over-year.
- TENAX THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $16.57M, a 46.17% increase year-over-year.
- TENAX THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $16.45M, a 125.48% increase year-over-year.
- TENAX THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $16.81M, a 263.84% increase year-over-year.
- TENAX THERAPEUTICS, INC. operating expenses for fiscal 2025 was $56.38M, a 189.24% increase from fiscal 2024.
- TENAX THERAPEUTICS, INC. operating expenses for fiscal 2024 was $19.49M, a 136.75% increase from fiscal 2023.
- TENAX THERAPEUTICS, INC. operating expenses for fiscal 2023 was $8.23M, a 25.50% decline from fiscal 2022.
- TENAX THERAPEUTICS, INC. operating expenses for fiscal 2022 was $11.05M, a 66.23% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 8 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 530 month | Operating Expenses 533 month | Operating Expenses 536 month | Operating Expenses 539 month | Operating Expenses 542 month | Operating Expenses 545 month | Operating Expenses 554 month | Operating Expenses 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.78M 10-Q · filed 2026-07-31 | $35.36M 10-Q · filed 2026-07-31 | $51.81M derived: sum of 3 quarters · filed 2026-07-31 | $68.61M derived: sum of 4 quarters · filed 2026-07-31 | |||||||||||||
| 2026-03-31 | $16.57M 10-Q · filed 2026-05-12 | $33.02M derived: sum of 2 quarters · filed 2026-05-12 | $49.83M derived: sum of 3 quarters · filed 2026-05-12 | $61.62M derived: sum of 4 quarters · filed 2026-07-31 | |||||||||||||
| 2025-12-31 | $16.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $33.26M derived: sum of 2 quarters · filed 2026-03-10 | $45.05M derived: sum of 3 quarters · filed 2026-07-31 | $56.38M 10-K · filed 2026-03-10 | |||||||||||||
| 2025-09-30 | $16.81M 10-Q · filed 2025-11-12 | $28.60M derived: sum of 2 quarters · filed 2026-07-31 | $39.94M 10-Q · filed 2025-11-12 | $47.23M derived: sum of 4 quarters · filed 2026-07-31 | |||||||||||||
| 2025-06-30 | $11.79M 10-Q · filed 2026-07-31 | $23.13M 10-Q · filed 2026-07-31 | $30.43M derived: sum of 3 quarters · filed 2026-07-31 | $35.04M derived: sum of 4 quarters · filed 2026-07-31 | |||||||||||||
| 2025-03-31 | $11.34M 10-Q · filed 2026-05-12 | $18.63M derived: sum of 2 quarters · filed 2026-05-12 | $23.25M derived: sum of 3 quarters · filed 2026-05-12 | $26.92M derived: sum of 4 quarters · filed 2026-05-12 | |||||||||||||
| 2024-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $11.91M derived: sum of 2 quarters · filed 2026-03-10 | $15.59M derived: sum of 3 quarters · filed 2026-03-10 | $19.49M 10-K · filed 2026-03-10 | |||||||||||||
| 2024-09-30 | $4.62M 10-Q · filed 2025-11-12 | $4.62M 10-Q · filed 2024-11-13 | $8.29M derived: sum of 2 quarters · filed 2025-11-12 | $12.20M 10-Q · filed 2025-11-12 | $12.20M 10-Q · filed 2024-11-13 | $15.54M derived: sum of 4 quarters · filed 2025-11-12 | |||||||||||
| 2024-06-30 | $3.67M 10-Q · filed 2025-08-13 | $3.67M 10-Q · filed 2024-08-13 | $7.58M 10-Q · filed 2025-08-13 | $7.58M 10-Q · filed 2024-08-13 | $10.92M derived: sum of 3 quarters · filed 2025-08-13 | $13.04M derived: sum of 4 quarters · filed 2025-08-13 | |||||||||||
| 2024-03-31 | $3.91M 10-Q · filed 2025-05-14 | $3.91M 10-Q · filed 2024-05-14 | $7.25M derived: sum of 2 quarters · filed 2025-05-14 | $9.37M derived: sum of 3 quarters · filed 2025-05-14 | $10.60M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||||||
| 2023-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $5.46M derived: sum of 2 quarters · filed 2025-03-25 | $6.69M derived: sum of 3 quarters · filed 2025-03-25 | $8.23M 10-K · filed 2025-03-25 | $8.23M 10-K · filed 2024-03-28 | ||||||||||||
| 2023-09-30 | $2.12M 10-Q · filed 2024-11-13 | $3.35M derived: sum of 2 quarters · filed 2024-11-13 | $4.89M 10-Q · filed 2024-11-13 | $7.45M derived: sum of 4 quarters · filed 2024-11-13 | |||||||||||||
| 2023-06-30 | $1.24M 10-Q · filed 2024-08-13 | $2.78M 10-Q · filed 2024-08-13 | $5.33M derived: sum of 3 quarters · filed 2024-08-13 | $8.25M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||
| 2023-03-31 | $1.54M 10-Q · filed 2024-05-14 | $4.09M derived: sum of 2 quarters · filed 2024-05-14 | $7.01M derived: sum of 3 quarters · filed 2024-05-14 | $9.87M derived: sum of 4 quarters · filed 2024-05-14 | |||||||||||||
| 2022-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $5.47M derived: sum of 2 quarters · filed 2024-03-28 | $8.33M derived: sum of 3 quarters · filed 2024-03-28 | $11.05M 10-K · filed 2024-03-28 | |||||||||||||
| 2022-09-30 | $2.92M 10-Q · filed 2023-11-13 | $5.78M derived: sum of 2 quarters · filed 2023-11-13 | $8.50M 10-Q · filed 2023-11-13 | $11.71M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2022-06-30 | $2.86M 10-Q · filed 2023-08-14 | $5.58M 10-Q · filed 2023-08-14 | $8.79M derived: sum of 3 quarters · filed 2023-08-14 | $12.59M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||
| 2022-03-31 | $2.72M 10-Q · filed 2023-05-15 | $5.93M derived: sum of 2 quarters · filed 2023-05-15 | $9.73M derived: sum of 3 quarters · filed 2023-05-15 | $11.70M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||||
| 2021-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $7.01M derived: sum of 2 quarters · filed 2023-03-31 | $8.98M derived: sum of 3 quarters · filed 2023-03-31 | $32.73M 10-K · filed 2023-03-31 | |||||||||||||
| 2021-09-30 | $3.80M 10-Q · filed 2022-11-10 | $5.77M derived: sum of 2 quarters · filed 2022-11-10 | $29.52M 10-Q · filed 2022-11-10 | $32.35M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||||||
| 2021-06-30 | $1.96M 10-Q · filed 2022-08-11 | $25.71M 10-Q · filed 2022-08-11 | $28.55M derived: sum of 3 quarters · filed 2022-08-11 | $30.77M derived: sum of 4 quarters · filed 2022-08-11 | |||||||||||||
| 2021-03-31 | $23.75M 10-Q · filed 2022-05-16 | -$23.75M 10-Q · filed 2021-05-17 | $26.58M derived: sum of 2 quarters · filed 2022-05-16 | $28.81M derived: sum of 3 quarters · filed 2022-05-16 | $30.95M derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $5.06M derived: sum of 2 quarters · filed 2022-03-29 | $7.20M derived: sum of 3 quarters · filed 2022-03-29 | $9.87M 10-K · filed 2022-03-29 | |||||||||||||
| 2020-09-30 | $2.23M 10-Q · filed 2021-11-15 | -$2.23M 10-Q · filed 2020-11-16 | $4.37M derived: sum of 2 quarters · filed 2021-11-15 | $7.03M 10-Q · filed 2021-11-15 | -$7.03M 10-Q · filed 2020-11-16 | $16.00M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||
| 2020-06-30 | $2.14M 10-Q · filed 2021-08-16 | -$2.14M 10-Q · filed 2020-08-14 | $4.81M 10-Q · filed 2021-08-16 | -$4.81M 10-Q · filed 2020-08-14 | $13.78M derived: sum of 3 quarters · filed 2021-08-16 | $11.52M derived: sum of 4 quarters · filed 2021-08-16 | |||||||||||
| 2020-03-31 | -$2.67M 10-Q · filed 2021-05-17 | $11.63M derived: sum of 2 quarters · filed 2021-05-17 | $9.37M derived: sum of 3 quarters · filed 2021-05-17 | $7.55M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||||||
| 2019-12-31 | $14.30M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $12.04M derived: sum of 2 quarters · filed 2021-04-16 | $10.22M derived: sum of 3 quarters · filed 2021-04-16 | $8.56M 10-K/A · filed 2021-04-16 | |||||||||||||
| 2019-09-30 | -$2.26M 10-Q · filed 2020-11-16 | -$4.08M derived: sum of 2 quarters · filed 2020-11-16 | -$5.74M 10-Q · filed 2020-11-16 | $5.82M derived: sum of 4 quarters · filed 2020-11-16 | |||||||||||||
| 2019-06-30 | -$1.82M 10-Q · filed 2020-08-14 | -$3.48M 10-Q · filed 2020-08-14 | $8.08M derived: sum of 3 quarters · filed 2020-08-14 | $6.52M derived: sum of 4 quarters · filed 2020-08-14 | |||||||||||||
| 2019-03-31 | -$1.66M 10-Q · filed 2020-05-15 | $9.90M derived: sum of 2 quarters · filed 2020-05-15 | $8.34M derived: sum of 3 quarters · filed 2020-05-15 | $6.45M derived: sum of 4 quarters · filed 2020-05-15 | |||||||||||||
| 2018-12-31 | $11.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $10.01M derived: sum of 2 quarters · filed 2020-03-30 | $8.12M derived: sum of 3 quarters · filed 2020-03-30 | $6.89M 10-K · filed 2020-03-30 | |||||||||||||
| 2018-09-30 | -$1.55M 10-Q · filed 2019-11-14 | -$3.44M derived: sum of 2 quarters · filed 2019-11-14 | -$4.67M 10-Q · filed 2019-11-14 | $12.36M derived: sum of 4 quarters · filed 2019-11-14 | |||||||||||||
| 2018-06-30 | -$1.89M 10-Q · filed 2019-08-14 | -$3.11M 10-Q · filed 2019-08-14 | $13.92M derived: sum of 3 quarters · filed 2019-08-14 | $12.61M derived: sum of 4 quarters · filed 2019-08-14 | |||||||||||||
| 2018-03-31 | -$1.22M 10-Q · filed 2019-05-15 | $15.81M derived: sum of 2 quarters · filed 2019-05-15 | $14.50M derived: sum of 3 quarters · filed 2019-05-15 | $11.48M derived: sum of 4 quarters · filed 2019-05-15 | |||||||||||||
| 2017-12-31 | $17.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $15.72M derived: sum of 2 quarters · filed 2019-04-01 | $12.70M derived: sum of 3 quarters · filed 2019-04-01 | $9.21M 10-K · filed 2019-04-01 | |||||||||||||
| 2017-09-30 | -$1.31M 10-Q · filed 2018-11-14 | -$4.32M derived: sum of 2 quarters · filed 2018-11-14 | -$7.82M 10-Q · filed 2018-11-14 | $59.70M derived: sum of 4 quarters · filed 2018-11-14 | |||||||||||||
| 2017-06-30 | -$3.01M 10-Q · filed 2018-08-14 | -$6.51M 10-Q · filed 2018-08-14 | $61.01M derived: sum of 3 quarters · filed 2018-08-14 | $56.51M derived: sum of 4 quarters · filed 2018-08-14 | |||||||||||||
| 2017-03-31 | -$3.50M 10-Q · filed 2018-05-15 | $3.50M 10-Q · filed 2017-05-10 | $64.03M derived: sum of 2 quarters · filed 2018-05-15 | $59.53M derived: sum of 3 quarters · filed 2018-05-15 | $54.86M derived: sum of 4 quarters · filed 2018-05-15 | ||||||||||||
| 2016-12-31 | $67.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $63.03M derived: sum of 2 quarters · filed 2018-04-02 | $58.36M derived: sum of 3 quarters · filed 2018-04-02 | $52.65M 10-K · filed 2018-04-02 | |||||||||||||
| 2016-09-30 | -$4.50M 10-Q · filed 2017-11-09 | $4.50M 10-Q · filed 2016-11-09 | -$9.17M derived: sum of 2 quarters · filed 2017-11-09 | -$14.88M 10-Q · filed 2017-11-09 | $14.88M 10-Q · filed 2016-11-09 | ||||||||||||
| 2016-06-30 | -$4.67M 10-Q · filed 2017-08-09 | $4.67M 10-Q · filed 2016-08-09 | -$10.38M 10-Q · filed 2017-08-09 | $10.38M 10-Q · filed 2016-08-09 | |||||||||||||
| 2016-03-31 | $5.71M 10-Q · filed 2017-05-10 | ||||||||||||||||
| 2015-12-31 | $10.43M 10-K · filed 2017-03-16 | ||||||||||||||||
| 2015-10-31 | $3.75M 10-Q · filed 2015-12-10 | $6.86M 10-Q · filed 2015-12-10 | |||||||||||||||
| 2015-09-30 | $3.10M 10-Q · filed 2016-11-09 | $11.22M 10-Q · filed 2016-11-09 | |||||||||||||||
| 2015-07-31 | $3.11M 10-Q · filed 2015-09-09 | ||||||||||||||||
| 2015-06-30 | $4.92M 10-Q · filed 2016-08-09 | $8.12M 10-Q · filed 2016-08-09 | |||||||||||||||
| 2015-04-30 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $14.87M 10-K · filed 2017-03-16 | |||||||||||||||
| 2015-03-31 | $3.20M 10-Q · filed 2016-05-10 | ||||||||||||||||
| 2015-01-31 | $3.13M 10-Q · filed 2015-03-17 | $7.28M derived: sum of 2 quarters · filed 2015-12-10 | $9.69M 10-Q · filed 2015-03-17 | $20.07M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||
| 2014-10-31 | $4.14M 10-Q · filed 2015-12-10 | $6.56M 10-Q · filed 2015-12-10 | $16.93M derived: sum of 3 quarters · filed 2017-03-16 | $19.40M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||
| 2014-07-31 | $2.42M 10-Q · filed 2015-09-09 | $12.79M derived: sum of 2 quarters · filed 2017-03-16 | $15.26M derived: sum of 3 quarters · filed 2017-03-16 | $17.43M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||||
| 2014-04-30 | $10.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $12.84M derived: sum of 2 quarters · filed 2017-03-16 | $15.01M derived: sum of 3 quarters · filed 2017-03-16 | $16.77M 10-K · filed 2017-03-16 | |||||||||||||
| 2014-01-31 | $2.47M 10-Q · filed 2015-03-17 | $4.64M derived: sum of 2 quarters · filed 2015-03-17 | $6.40M 10-Q · filed 2015-03-17 | $7.82M derived: sum of 4 quarters · filed 2016-03-14 | $82.13M 10-Q · filed 2014-03-17 | ||||||||||||
| 2013-10-31 | $2.17M 10-Q · filed 2014-12-15 | $3.93M 10-Q · filed 2014-12-15 | $5.35M derived: sum of 3 quarters · filed 2016-03-14 | $7.16M derived: sum of 4 quarters · filed 2016-03-14 | $79.65M 10-Q · filed 2013-12-17 | ||||||||||||
| 2013-07-31 | $1.76M 10-Q · filed 2014-09-15 | $3.18M derived: sum of 2 quarters · filed 2016-03-14 | $4.99M derived: sum of 3 quarters · filed 2016-03-14 | $6.19M derived: sum of 4 quarters · filed 2016-03-14 | $77.48M 10-Q · filed 2013-09-17 | ||||||||||||
| 2013-04-30 | $1.42M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $3.23M derived: sum of 2 quarters · filed 2016-03-14 | $4.43M derived: sum of 3 quarters · filed 2016-03-14 | $6.38M 10-KT · filed 2016-03-14 | $75.73M 10-K · filed 2013-06-26 | ||||||||||||
| 2013-01-31 | $1.81M 10-Q · filed 2014-03-17 | $3.01M derived: sum of 2 quarters · filed 2014-03-17 | $4.96M 10-Q · filed 2014-03-17 | $6.92M derived: sum of 4 quarters · filed 2014-03-17 | $74.31M 10-Q · filed 2013-03-18 | ||||||||||||
| 2012-10-31 | $1.20M 10-Q · filed 2013-12-17 | $3.15M 10-Q · filed 2013-12-17 | $5.10M derived: sum of 3 quarters · filed 2013-12-17 | $7.13M derived: sum of 4 quarters · filed 2013-12-17 | $72.49M 10-Q · filed 2012-12-14 | ||||||||||||
| 2012-07-31 | $1.95M 10-Q · filed 2013-09-17 | $3.91M derived: sum of 2 quarters · filed 2013-09-17 | $5.93M derived: sum of 3 quarters · filed 2013-09-17 | $8.08M derived: sum of 4 quarters · filed 2013-09-17 | $71.30M 10-Q · filed 2012-09-19 | ||||||||||||
| 2012-04-30 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $3.98M derived: sum of 2 quarters · filed 2013-06-26 | $6.13M derived: sum of 3 quarters · filed 2013-06-26 | $8.58M 10-K · filed 2013-06-26 | $69.35M 10-K · filed 2012-07-25 | ||||||||||||
| 2012-01-31 | $2.02M 10-Q · filed 2013-03-18 | $4.17M derived: sum of 2 quarters · filed 2013-03-18 | $6.62M 10-Q · filed 2013-03-18 | $9.40M derived: sum of 4 quarters · filed 2013-03-18 | $67.39M 10-Q · filed 2012-03-15 | ||||||||||||
| 2011-10-31 | $2.15M 10-Q · filed 2012-12-14 | $4.60M 10-Q · filed 2012-12-14 | $7.37M derived: sum of 3 quarters · filed 2012-12-14 | $10.16M derived: sum of 4 quarters · filed 2012-12-14 | $65.37M 10-Q · filed 2011-12-15 | ||||||||||||
| 2011-07-31 | $2.45M 10-Q · filed 2012-09-19 | $5.23M derived: sum of 2 quarters · filed 2012-09-19 | $8.01M derived: sum of 3 quarters · filed 2012-09-19 | $10.09M derived: sum of 4 quarters · filed 2012-09-19 | $63.22M 10-Q · filed 2011-09-19 | ||||||||||||
| 2011-04-30 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $5.55M derived: sum of 2 quarters · filed 2012-07-25 | $7.64M derived: sum of 3 quarters · filed 2012-07-25 | $10.67M 10-K · filed 2012-07-25 | |||||||||||||
| 2011-01-31 | $2.78M 10-Q · filed 2012-03-15 | $4.87M derived: sum of 2 quarters · filed 2012-03-15 | $7.89M 10-Q · filed 2012-03-15 | ||||||||||||||
| 2010-10-31 | $2.08M 10-Q · filed 2011-12-15 | $5.11M 10-Q · filed 2011-12-15 | |||||||||||||||
| 2010-07-31 | $3.03M 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |